|Day's range||6.41 - 6.41|
In the latest trading session, Novo Nordisk (NVO) closed at $155.32, marking a +0.4% move from the previous day.
Does Novo Nordisk (NVO) have what it takes to be a top stock pick for momentum investors? Let's find out.
Novo Nordisk (NVO) announces positive top-line results from its phase III increased dosage study of semaglutide, 25 mg and 50 mg, for the treatment of patients with type II diabetes.